Clinical trial
Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset:Longterm Outcome Analysis
NCT05039697 is registered in ClinicalTrials.gov with Capital Medical University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Normobaric Hyperoxia Combined With Endovascular Therapy in Patients With Stroke Within 6 Hours of Onset:Longterm Outcome Analysis
- Lead sponsor
- Capital Medical University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- April 22, 2021
- Completion date
- February 4, 2024
- Enrollment
- 282 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
endovascular treatment, hypoxia-ischemia, brain, stroke, acute